Lamotrin-Mepha 25 mg, Tabletten - 60 Tablette(n) Swissmedic Key 57137010 Registration Holder Mepha Pharma AG Name Lamotrin-Mepha 25 mg, Tabletten Date of registration 14.07.2005 Original/Generic Generic Introduction of Sequence 14.07.2005 ATC-Classification Lamotrigine (N03AX09) Revision date WHO WHO-DDD Valid until Index Therapeuticus (BSV) 01.07.10. Show package size 60 Tablette(n) Index Therapeuticus (Swissmedic) 01.07.10. Description Swissmedic categorie. B SL Eintrag Yes Indication Information for professionals IP Consumer information CI Ex-factory-Price 7.58 Limitation No Deductible 10 % Consumer price 17.45 Feedback FB Daily cost GTIN 7680571370103 Medication Code Synthetika Pharmacode 3013552 Disponibility
Composition lamotriginum 25 mg, calcii carbonas, sorbitolum 2.917 mg, cellulosum microcristallinum silicificatum, crospovidonum, maydis amylum, talcum, natrii stearylis fumaras, silica colloidalis anhydrica, aromatica, saccharinum natricum corresp. natrium 0.206 mg pro compresso. Packungsbestandteile Galenic Form Tablets Active Agent Dose Lamotrigine 25 mg
BAG: Active Agent Dose Lamotrigine 25 mg
Inactive agents Dose Aromatica Calcium Carbonate Cellulosum Microcristallinum Silicificatum Crospovidonum Maydis Amylum Natrii Stearylis Fumaras Pro Compresso Saccharinum Natricum Silica Colloidalis Anhydrica Sorbitol 2.917 mg Talcum
Source Data was imported : 05.04.2020
Swissmedic Registration :
Sequence :
Product name :
Registration owner: :
Product group :
Index Therapeuticus (BSV) :
Medication Code :
Date of registration :
Valid until :
Package number :
Show package size :
Commercial Form/Unit :
Swissmedic categorie. :
Active Agents :
Composition :
